Mayne Pharma Group |
High $4.46 |
Low $4.23 |
Trades 1,020 |
Turnover $2,463,536 |
Volume 565,229 |
| 30 June 2023 at 4:10pm | ||||
|
Market Cap (13-Nov) $277,610,112 (439th) |
Close (30-Jun) $4.40 |
Volume (30-Jun) 565,229 |
Shortsold (6-Nov) 1,890,557 (2.31%) (155th) |
|
52w High $6.04 |
52w Low $2.04 |
P/E 263.16 |
EPS 0.31 |
Update - Notification of buy-back - MYX
MYX released this announcement to the ASX on 18 January 2023, 9:21. The announcement is not marked as price sensitive, and is 6 page(s) in length and 24.18kb in size.
You can view all announcements from MYX and see how they appear on a price chart on the announcements page.
At the date of this announcement, MYX was 0.476% short sold according to ASIC data. It was ranked the 306th most shorted stock on the ASX. It is now ranked as the 155th most shorted stock on the ASX with 2.309% of total shares short sold as of the latest reported data (06 November 2026).
| Other Recent Announcements from MYX | |
|---|---|
| Notification of cessation of securities - MYX | 30 June 2023, 16:11 |
| Update - Notification of buy-back - MYX | 30 June 2023, 8:19 |
| Update - Notification of buy-back - MYX | 29 June 2023, 8:20 |
| Update - Notification of buy-back - MYX | 18 January 2023, 9:21 |
| US launch of HALOETTE, a generic version of NUVARING | 13 January 2023, 8:26 |
| Return of Capital - MYX (updated) | 12 January 2023, 16:53 |
| JP Morgan Healthcare Conference Presentation | 12 January 2023, 8:25 |
If you were already registered, log in here.